药明生物(02269)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02269 药明生物

未开盘 12-20 16:08:10

17.020

+0.060

+0.35%

最高17.320	最低16.820	成交量2,867万
今开17.000	昨收16.960	日振幅2.95%
总市值698.67亿	流通市值698.67亿	总股本41.05亿
成交额4.90亿	换手率0.70%	流通股本41.05亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02269","market":"HK","secType":"STK","nameCN":"药明生物","latestPrice":17.02,"timestamp":1734682090015,"preClose":16.96,"halted":0,"volume":28667065,"delay":0,"floatShares":4104999999,"shares":4104999999,"eps":0.8707007,"marketStatus":"未开盘","marketStatusCode":0,"change":0.06,"latestTime":"12-20 16:08:10","open":17,"high":17.32,"low":16.82,"amount":489914850,"amplitude":0.029481,"askPrice":17.06,"askSize":437500,"bidPrice":17.02,"bidSize":167500,"shortable":3,"etf":0,"ttmEps":0.6396749577819589,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734917400000},"adr":0,"listingDate":1497283200000,"adjPreClose":16.96,"adrRate":0,"openAndCloseTimeList":[[1734658200000,1734667200000],[1734670800000,1734681600000]],"volumeRatio":0.7535062313110235,"impliedVol":0.5411,"impliedVolPercentile":0.1862,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"WXB.HK"},"requestUrl":"/m/hq/s/02269/tweets","defaultTab":"tweets","newsList":[{"id":"2493232541","title":"制裁风险暂时解除后，药明生物与美国药企就ADC新药达成合作，总交易额超8亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493232541","media":"时代周报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493232541?lang=zh_cn&edition=full","pubTime":"2024-12-21 19:47","pubTimestamp":1734781667,"startTime":"0","endTime":"0","summary":"继美国2025年度国防授权法案未将《生物安全法案》纳入的消息传出后，药明生物（02269.HK）再度迎来好消息。12月20日，药明生物宣布和杭州多禧生物科技有限公司（下称“多禧生物”）与AadiBioscience（下称“Aadi”）达成研究服务合作协议，赋能Aadi公司研发三款处于临床前阶段的新一代抗体偶联药物（ADC，Antibody-drugconjugates）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412213275080854.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1880383366.USD","LU0140636845.USD","LU0516422952.EUR","LU0516423091.SGD","LU0326950275.SGD","LU1242518931.SGD","02269","LU2039709279.SGD","LU0052750758.USD","SG9999002463.SGD","BK4231","LU0819121731.USD","BK1589","LU0320764599.SGD","LU0359201612.USD","BK1610","LU0043850808.USD","LU0417516902.SGD","LU0979878070.USD","SG9999002562.SGD","LU0307460666.USD","LU0588546209.SGD","BK4080","BK1521","LU0051755006.USD","LU0708995583.HKD","LU0823426308.USD","ADC","LU0348825331.USD","LU0417516738.SGD","LU0039217434.USD","LU0456846285.SGD","LU0516423174.USD","LU1242518857.USD","LU0823426480.USD","LU0359202008.SGD","LU0181495838.USD","LU0348735423.USD","IE00B0JY6N72.USD","LU0516422440.USD","LU0456827905.SGD","LU1794554557.SGD","LU0572944931.SGD","LU0327786744.USD","LU0856984785.SGD","LU1720050803.USD","LU0516422366.SGD","LU1688375341.USD","BK1141","BK1576"],"gpt_icon":0},{"id":"2492416483","title":"BUZZ-阿迪生物科学公司因癌症药物许可协议而获益","url":"https://stock-news.laohu8.com/highlight/detail?id=2492416483","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492416483?lang=zh_cn&edition=full","pubTime":"2024-12-20 19:20","pubTimestamp":1734693630,"startTime":"0","endTime":"0","summary":"** AADI表示，它与中国生物技术公司药明康德2269.HK和杭州达克生物科技有限公司达成了 ，开发并可能销售三种实验性抗体药物共轭物 治疗方法。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nL4T3NL0PH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","LU0819121731.USD","LU0588546209.SGD","LU0307460666.USD","LU0320764599.SGD","LU0516422440.USD","LU2039709279.SGD","LU0348825331.USD","LU0359201612.USD","LU0326950275.SGD","BK1576","LU0572944931.SGD","LU0516423091.SGD","LU0456827905.SGD","BK4139","LU0348735423.USD","LU0708995583.HKD","LU0052750758.USD","IE00B0JY6N72.USD","LU0516422366.SGD","LU0823426308.USD","SG9999002463.SGD","LU0823426480.USD","02269","LU0516422952.EUR","LU1720050803.USD","LU0039217434.USD","LU0516423174.USD","AADI","LU0856984785.SGD","LU1880383366.USD","LU1242518931.SGD","LU0417516902.SGD","LU0417516738.SGD","LU0140636845.USD","LU1242518857.USD","LU0051755006.USD","BK1141","LU0359202008.SGD","LU0181495838.USD","LU0043850808.USD","LU0456846285.SGD","LU0979878070.USD","LU0327786744.USD","BK1610","LU1794554557.SGD","LU1688375341.USD","BK1521","SG9999002562.SGD"],"gpt_icon":0},{"id":"2492143018","title":"药明生物12月19日遭南向资金减持404.25万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492143018","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492143018?lang=zh_cn&edition=full","pubTime":"2024-12-20 09:30","pubTimestamp":1734658220,"startTime":"0","endTime":"0","summary":"截止当日收盘，港股通共持有药明生物114080.95万股，占流通股27.78%。港股通减持金额前五个股分别为美团-W、小米集团-W、中芯国际、金山云、洛阳钼业。药明生物近5个交易日下跌6.61%，港股通累计减持3282.13万股；近20个交易日上涨13.07%，港股通累计减持12310.34万股。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220093623ab85b0b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220093623ab85b0b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348735423.USD","LU0456827905.SGD","LU0516422440.USD","LU0051755006.USD","SG9999002562.SGD","LU0181495838.USD","LU0043850808.USD","02269","BK1521","LU0307460666.USD","LU0819121731.USD","LU0516422366.SGD","LU0979878070.USD","LU0417516738.SGD","LU1720050803.USD","LU2039709279.SGD","LU0856984785.SGD","LU0823426308.USD","LU1794554557.SGD","LU0456846285.SGD","LU0516422952.EUR","LU0348825331.USD","LU0823426480.USD","LU0359202008.SGD","LU0039217434.USD","BK1576","BK1610","LU1242518857.USD","LU1880383366.USD","LU0359201612.USD","BK1141","LU0572944931.SGD","LU0327786744.USD","LU0516423174.USD","SG9999002463.SGD","LU0516423091.SGD","LU1242518931.SGD","LU1688375341.USD","LU0588546209.SGD","LU0052750758.USD","LU0417516902.SGD","BK1589","LU0320764599.SGD","LU0326950275.SGD","IE00B0JY6N72.USD","LU0708995583.HKD","LU0140636845.USD"],"gpt_icon":0},{"id":"2492459956","title":"药明生物：与多禧达成合作 获超 8 亿美元款","url":"https://stock-news.laohu8.com/highlight/detail?id=2492459956","media":"和讯网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492459956?lang=zh_cn&edition=full","pubTime":"2024-12-20 09:21","pubTimestamp":1734657705,"startTime":"0","endTime":"0","summary":"【12 月 20 日，药明生物披露与杭州多禧生物科技有限公司及 AadiBioscience 达成研究服务合作协议，助力 AADI 公司研发三款临床前阶段的新一代抗体偶联药物(ADCs)。】根据协议，Aadi 公司将向药明生物和多禧生物给付 4400 万美元首付款，最高可达 2.65 亿美元的开发里程碑付款、5.4 亿美元的商业里程碑付款，还有个位数比例的销售提成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220103831ab85d4fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220103831ab85d4fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0043850808.USD","LU0359201612.USD","SG9999002562.SGD","IE00B0JY6N72.USD","LU0456846285.SGD","LU0823426480.USD","LU0856984785.SGD","LU0326950275.SGD","LU0417516902.SGD","BK1521","LU0819121731.USD","LU2039709279.SGD","LU0307460666.USD","LU0348825331.USD","LU0572944931.SGD","LU1242518931.SGD","LU0588546209.SGD","LU0327786744.USD","02269","LU0140636845.USD","LU0456827905.SGD","LU0516422366.SGD","LU0823426308.USD","LU1242518857.USD","BK1610","LU0516422440.USD","LU0039217434.USD","LU0516423174.USD","LU0417516738.SGD","BK1141","LU0051755006.USD","LU1794554557.SGD","BK1576","BK1589","LU0516423091.SGD","LU1880383366.USD","SG9999002463.SGD","LU0320764599.SGD","LU0708995583.HKD","LU0181495838.USD","LU0516422952.EUR","LU0979878070.USD","LU1688375341.USD","LU0348735423.USD","LU0359202008.SGD","LU1720050803.USD","LU0052750758.USD"],"gpt_icon":0},{"id":"2492370654","title":"药明生物(02269)和多禧生物与Aadi Bioscience(AADI.US)就三款创新ADC达成研究服务合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2492370654","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492370654?lang=zh_cn&edition=full","pubTime":"2024-12-20 09:21","pubTimestamp":1734657690,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，全球领先的合同研究、开发和生产服务公司药明生物今日宣布和杭州多禧生物科技有限公司与Aadi Bioscience达成研究服务合作协议，赋能Aadi公司研发三款处于临床前阶段的新一代抗体偶联药物。Aadi Bioscience总裁兼首席执行官David Lennon博士指出，我们很高兴与药明生物和多禧生物达成合作，推进这些创新产品研发。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227419.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0052750758.USD","LU0516422366.SGD","LU0516423174.USD","BK4080","AADI","LU0039217434.USD","LU0051755006.USD","LU0979878070.USD","LU1880383366.USD","BK4139","LU0417516902.SGD","LU0516423091.SGD","LU0456846285.SGD","BK1610","BK1589","LU0823426308.USD","BK1521","LU0181495838.USD","LU1720050803.USD","02269","LU0588546209.SGD","LU0359202008.SGD","LU1688375341.USD","BK1576","SG9999002463.SGD","LU0326950275.SGD","LU0348735423.USD","LU0417516738.SGD","LU1794554557.SGD","LU0823426480.USD","LU0043850808.USD","LU0856984785.SGD","LU0516422952.EUR","LU0307460666.USD","BK1141","LU0327786744.USD","LU2039709279.SGD","ADC","LU0320764599.SGD","LU0708995583.HKD","BK4231","LU0140636845.USD","IE00B0JY6N72.USD","LU0516422440.USD","LU1242518857.USD","LU0359201612.USD","LU1242518931.SGD","SG9999002562.SGD","LU0348825331.USD","LU0572944931.SGD"],"gpt_icon":0},{"id":"2492583979","title":"港股收盘，恒指收涨0.83%，恒生科技指数收涨1.82%，生物技术板块午后走强，歌礼制药(01672.HK)收涨19.33%，药明生物(02269.","url":"https://stock-news.laohu8.com/highlight/detail?id=2492583979","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492583979?lang=zh_cn&edition=full","pubTime":"2024-12-18 16:10","pubTimestamp":1734509424,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1576","LU2039709279.SGD","513600","LU0516423174.USD","HSI","LU0359202008.SGD","LU1242518931.SGD","01672","LU0326950275.SGD","LU1880383366.USD","LU0516422366.SGD","YANG","BK1141","LU0039217434.USD","LU0051755006.USD","LU1720050803.USD","02269","LU0307460666.USD","IE00B0JY6N72.USD","LU0320764599.SGD","LU0359201612.USD","02833","LU0572944931.SGD","LU1242518857.USD","LU0516422440.USD","MCHmain","LU0348735423.USD","LU1688375341.USD","SG9999002562.SGD","01477","LU0979878070.USD","LU0417516902.SGD","HSImain","LU0181495838.USD","BK1521","LU0043850808.USD","HHImain","HSCEI","LU0140636845.USD","LU0327786744.USD","MHImain","BK1515","LU0516422952.EUR","LU0708995583.HKD","07226","LU0823426480.USD","BK1589","LU1794554557.SGD","BK1610","HSTECH"],"gpt_icon":0},{"id":"1134817218","title":"《生物安全法案》未被美国国会纳入2025年持续拨款和延期法案","url":"https://stock-news.laohu8.com/highlight/detail?id=1134817218","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134817218?lang=zh_cn&edition=full","pubTime":"2024-12-18 15:56","pubTimestamp":1734508611,"startTime":"0","endTime":"0","summary":"也未出现药明系和华大智造等相关实体名称。","market":"hk","thumbnail":"https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359","02268","688114","02269"],"gpt_icon":0},{"id":"2492976528","title":"药明生物(02269)上涨2.38%，报17.24元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492976528","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492976528?lang=zh_cn&edition=full","pubTime":"2024-12-18 15:53","pubTimestamp":1734508436,"startTime":"0","endTime":"0","summary":"12月18日，药明生物(02269)盘中上涨2.38%，截至15:53，报17.24元/股，成交3.21亿元。药明生物技术有限公司是全球领先的生物制剂服务供应商，提供全面、综合及高度定制的服务，包括从发现、开发到生产生物制剂的全过程。公司在2016年在中国生物制剂研发市场占有48%的市场份额，已与全球20大制药公司中的12家建立合作关系。截至2024年中报，药明生物营业总收入85.74亿元、净利润14.99亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/18155346533475.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0856984785.SGD","LU0348735423.USD","LU1880383366.USD","LU0348825331.USD","BK1610","LU0823426308.USD","LU0516423174.USD","LU0326950275.SGD","BK1141","LU0979878070.USD","LU0039217434.USD","LU0456827905.SGD","LU0359201612.USD","LU0516422366.SGD","LU0052750758.USD","BK1589","LU0456846285.SGD","LU1242518931.SGD","LU0359202008.SGD","LU0051755006.USD","LU0320764599.SGD","LU1720050803.USD","LU0823426480.USD","LU0140636845.USD","BK1576","LU0708995583.HKD","02269","LU1242518857.USD","LU1688375341.USD","LU0516422952.EUR","IE00B0JY6N72.USD","LU0043850808.USD","LU0516423091.SGD","LU0572944931.SGD","LU0417516902.SGD","LU0181495838.USD","BK1521","SG9999002463.SGD","LU0417516738.SGD","LU0307460666.USD","LU2039709279.SGD","SG9999002562.SGD","LU0516422440.USD","LU1794554557.SGD","LU0819121731.USD","LU0588546209.SGD","LU0327786744.USD"],"gpt_icon":0},{"id":"2492949603","title":"药明生物12月17日遭南向资金减持919.47万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492949603","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492949603?lang=zh_cn&edition=full","pubTime":"2024-12-18 09:30","pubTimestamp":1734485421,"startTime":"0","endTime":"0","summary":"12月17日，南向资金减持药明生物919.47万股连续6日减持。截止当日收盘，港股通共持有药明生物115881.83万股，占流通股28.22%。药明生物近5个交易日下跌7.78%，港股通累计减持6312.80万股；近20个交易日上涨10.79%，港股通累计减持10625.81万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218093637ab807e14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218093637ab807e14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2039709279.SGD","LU0516422440.USD","BK1576","LU0326950275.SGD","LU0327786744.USD","LU0588546209.SGD","BK1521","LU0516423174.USD","LU0456827905.SGD","LU0039217434.USD","LU0708995583.HKD","LU0320764599.SGD","02269","LU0140636845.USD","LU0307460666.USD","LU0819121731.USD","LU0979878070.USD","LU0456846285.SGD","SG9999002562.SGD","LU0823426480.USD","LU0516423091.SGD","LU1242518931.SGD","LU0516422952.EUR","BK1610","LU0359201612.USD","LU0572944931.SGD","LU0417516902.SGD","LU1880383366.USD","LU0516422366.SGD","LU0348735423.USD","LU0181495838.USD","LU0359202008.SGD","LU0856984785.SGD","LU0043850808.USD","BK1589","SG9999002463.SGD","BK1141","LU0417516738.SGD","LU0823426308.USD","LU1242518857.USD","LU1794554557.SGD","LU0052750758.USD","LU1720050803.USD","IE00B0JY6N72.USD","LU1688375341.USD","LU0051755006.USD","LU0348825331.USD"],"gpt_icon":0},{"id":"2492090116","title":"港股午评：恒指早间宽幅震荡 中特估板块持续强势","url":"https://stock-news.laohu8.com/highlight/detail?id=2492090116","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492090116?lang=zh_cn&edition=full","pubTime":"2024-12-17 12:05","pubTimestamp":1734408343,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"47cfaf5f7b82df8229b96996535ec1c8","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["SG9999001226.SGD","LU0348825331.USD","00883","BK1521","MHImain","159796","LU0823426480.USD","02833","80883","BK0012","02269","LU0516423174.USD","LU0140636845.USD","HSTECH","BK1149","BK0167","BK1515","HHImain","BK1610","HSI","BK0028","000063","00763","BK0125","LU0531971595.HKD","LU1880383366.USD","YANG","00780","LU0149721374.USD","513600","LU0516422366.SGD","MCHmain","LU1781817850.SGD","07226","LU0043850808.USD","159938","09939","BK1607","HSImain","BK1604","LU0348735423.USD","SGXZ90724238.SGD","LU0516422440.USD","LU0039217434.USD","BK1506","LU0164880469.USD","LU0164865239.USD","BK1164","HSCEI","BK0000"],"gpt_icon":0},{"id":"2492674803","title":"南向资金12月16日净卖出药明生物99.43万股 连续5日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2492674803","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492674803?lang=zh_cn&edition=full","pubTime":"2024-12-17 09:30","pubTimestamp":1734399019,"startTime":"0","endTime":"0","summary":"12月16日，南向资金减持药明生物99.43万股连续5日减持。截止当日收盘，港股通共持有药明生物116801.30万股，占流通股28.44%。药明生物近5个交易日下跌9.05%，港股通累计减持6353.98万股；近20个交易日上涨16.29%，港股通累计减持9602.68万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217093232ab7dbe25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217093232ab7dbe25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0051755006.USD","LU1242518857.USD","LU0307460666.USD","LU0039217434.USD","LU1794554557.SGD","LU0348825331.USD","SG9999002562.SGD","LU1688375341.USD","BK1576","LU1242518931.SGD","LU0588546209.SGD","BK1610","LU0516423174.USD","LU0327786744.USD","BK1521","02269","LU0516422952.EUR","LU1880383366.USD","LU0043850808.USD","LU0516422440.USD","LU0359201612.USD","LU0516423091.SGD","LU0052750758.USD","LU0572944931.SGD","LU2039709279.SGD","LU0456827905.SGD","LU0359202008.SGD","LU0819121731.USD","BK1141","LU0348735423.USD","LU0326950275.SGD","LU0417516902.SGD","LU0856984785.SGD","SG9999002463.SGD","LU0320764599.SGD","LU0823426308.USD","LU0708995583.HKD","BK1589","LU0456846285.SGD","LU1720050803.USD","LU0181495838.USD","IE00B0JY6N72.USD","LU0823426480.USD","LU0516422366.SGD","LU0979878070.USD","LU0140636845.USD","LU0417516738.SGD"],"gpt_icon":0},{"id":"2491966659","title":"药明生物12月16日主力大幅流出1.05亿元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2491966659","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491966659?lang=zh_cn&edition=full","pubTime":"2024-12-16 16:16","pubTimestamp":1734336967,"startTime":"0","endTime":"0","summary":"12月16日, 药明生物股价跌2.92%，报收17.28元，成交金额7.78亿元，换手率1.09%，振幅4.49%，量比0.54。药明生物今日主力资金净流出1.05亿元，上一交易日主力净流入585万元。该股近5个交易日下跌8.84%，主力资金累计净流出8967万元；近20日主力资金累计净流入1.58亿元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216161638a1f27a05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216161638a1f27a05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0516422440.USD","LU1880383366.USD","LU0307460666.USD","LU0516422366.SGD","LU0320764599.SGD","LU1242518931.SGD","LU0456827905.SGD","LU0588546209.SGD","SG9999002562.SGD","LU1688375341.USD","LU0326950275.SGD","LU0516422952.EUR","LU0823426308.USD","LU0140636845.USD","LU0417516902.SGD","LU0052750758.USD","LU1720050803.USD","LU2039709279.SGD","LU0417516738.SGD","LU0456846285.SGD","LU0181495838.USD","LU0051755006.USD","LU0348735423.USD","LU0348825331.USD","LU0039217434.USD","LU0819121731.USD","LU0572944931.SGD","LU0043850808.USD","LU0327786744.USD","LU0823426480.USD","LU1794554557.SGD","LU0856984785.SGD","LU0516423091.SGD","LU0708995583.HKD","LU0979878070.USD","02269","LU0359201612.USD","BK1576","SG9999002463.SGD","LU0516423174.USD","LU0359202008.SGD","LU1242518857.USD","BK1589","BK1610","IE00B0JY6N72.USD","BK1141","BK1521"],"gpt_icon":1},{"id":"2491630509","title":"医药股多数承压 来凯医药(02105)跌近11% 机构指板块当前已经处于业绩、政策和资金三重反转的进程中","url":"https://stock-news.laohu8.com/highlight/detail?id=2491630509","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491630509?lang=zh_cn&edition=full","pubTime":"2024-12-16 14:56","pubTimestamp":1734332198,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药股多数承压，来凯医药 跌10.94%，康诺亚跌6.07%，金斯瑞生物科技跌5.54%，科伦博泰生物跌4.96%，康方生物跌4.4%，药明生物跌3.15%。国金证券发研指，医药板块当前已经处于业绩、政策和资金三重反转的进程之中，对2025年医药板块上市公司营收利润增速回升、板块行情复苏有充分信心。医保局将指导各地及中选企业做好中选结果落地实施工作，确保全国患者于2025年4月用上本次集采中选产品。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210810/ZTUyNTQ0NjcxODUwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZTUyNTQ0NjcxODUwNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1949709","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","LU0140636845.USD","LU0348783233.USD","LU0516423091.SGD","LU0359202008.SGD","LU0516423174.USD","LU0307460666.USD","01548","LU0320764599.SGD","LU0043850808.USD","LU0326950275.SGD","LU0348825331.USD","LU0516422952.EUR","LU0348784397.USD","LU1242518857.USD","IE00B0JY6N72.USD","BK1587","LU0181495838.USD","LU0348735423.USD","LU1880383366.USD","HK0000320223.HKD","06990","LU2039709279.SGD","LU0456827905.SGD","HK0000306701.USD","02105","159938","BK1521","LU0456846285.SGD","SG9999002463.SGD","HK0000306685.HKD","09939","09926","BK1583","IE00B5MMRT66.SGD","LU0051755006.USD","LU0979878070.USD","LU0823426480.USD","LU2488822045.USD","LU0417516571.SGD","02162","LU0359201612.USD","LU1242518931.SGD","LU0516422366.SGD","LU0823426308.USD","BK1574","02269","LU0572944931.SGD","LU0588546209.SGD","LU1720050803.USD"],"gpt_icon":1},{"id":"2491563104","title":"药明生物(02269)下跌2.36%，报17.38元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2491563104","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491563104?lang=zh_cn&edition=full","pubTime":"2024-12-16 13:47","pubTimestamp":1734328059,"startTime":"0","endTime":"0","summary":"12月16日，药明生物(02269)盘中下跌2.36%，截至13:47，报17.38元/股，成交3.0亿元。药明生物技术有限公司是全球领先的生物制剂服务供应商，提供全面、综合及高度定制的服务，包括从发现、开发到生产生物制剂的全过程。公司在2016年在中国生物制剂研发市场占有48%的市场份额，已与全球20大制药公司中的12家建立合作关系。截至2024年中报，药明生物营业总收入85.74亿元、净利润14.99亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/16134746412730.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0359201612.USD","LU1242518931.SGD","LU0823426308.USD","BK1610","LU1688375341.USD","BK1141","LU0456827905.SGD","BK1589","SG9999002562.SGD","LU0326950275.SGD","LU0708995583.HKD","LU0181495838.USD","IE00B0JY6N72.USD","LU0417516738.SGD","LU0348825331.USD","LU0456846285.SGD","LU0052750758.USD","LU0516422952.EUR","LU0979878070.USD","BK1576","LU0516423091.SGD","LU1720050803.USD","LU0588546209.SGD","LU0359202008.SGD","LU0039217434.USD","LU1794554557.SGD","LU0140636845.USD","LU1242518857.USD","SG9999002463.SGD","LU0320764599.SGD","LU0348735423.USD","LU0572944931.SGD","LU0327786744.USD","LU1880383366.USD","LU0307460666.USD","02269","LU0516422440.USD","LU0051755006.USD","LU0043850808.USD","LU0516422366.SGD","LU0856984785.SGD","LU0516423174.USD","LU2039709279.SGD","LU0823426480.USD","LU0417516902.SGD","BK1521","LU0819121731.USD"],"gpt_icon":0},{"id":"2491686141","title":"药明生物12月13日遭南向资金减持462.35万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2491686141","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491686141?lang=zh_cn&edition=full","pubTime":"2024-12-16 09:30","pubTimestamp":1734312619,"startTime":"0","endTime":"0","summary":"12月13日，南向资金减持药明生物462.35万股连续4日减持。截止当日收盘，港股通共持有药明生物116900.73万股，占流通股28.46%。药明生物近5个交易日上涨2.65%，港股通累计减持5873.60万股；近20个交易日上涨18.51%，港股通累计减持8230.95万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216093221ab7af9fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216093221ab7af9fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1880383366.USD","LU0140636845.USD","LU0516422952.EUR","LU0516423091.SGD","LU0326950275.SGD","LU1242518931.SGD","02269","LU2039709279.SGD","LU0052750758.USD","SG9999002463.SGD","LU0819121731.USD","BK1589","LU0320764599.SGD","LU0359201612.USD","BK1610","LU0043850808.USD","LU0417516902.SGD","LU0979878070.USD","SG9999002562.SGD","LU0307460666.USD","LU0588546209.SGD","BK1521","LU0051755006.USD","LU0708995583.HKD","LU0823426308.USD","LU0348825331.USD","LU0417516738.SGD","LU0039217434.USD","LU0456846285.SGD","LU0516423174.USD","LU1242518857.USD","LU0823426480.USD","LU0359202008.SGD","LU0181495838.USD","LU0348735423.USD","IE00B0JY6N72.USD","LU0516422440.USD","LU0456827905.SGD","LU1794554557.SGD","LU0572944931.SGD","LU0327786744.USD","LU0856984785.SGD","LU1720050803.USD","LU0516422366.SGD","LU1688375341.USD","BK1141","BK1576"],"gpt_icon":1},{"id":"2491065311","title":"药明生物(02269)下跌2.09%，报17.78元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2491065311","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491065311?lang=zh_cn&edition=full","pubTime":"2024-12-13 14:46","pubTimestamp":1734072378,"startTime":"0","endTime":"0","summary":"12月13日，药明生物(02269)盘中下跌2.09%，截至14:46，报17.78元/股，成交5.65亿元。药明生物技术有限公司是全球领先的生物制剂服务供应商，提供全面、综合及高度定制的服务，包括从发现、开发到生产生物制剂的全过程。公司在2016年在中国生物制剂研发市场占有48%的市场份额，已与全球20大制药公司中的12家建立合作关系。截至2024年中报，药明生物营业总收入85.74亿元、净利润14.99亿元。12月12日，招银国际维持买入评级,目标价上调至22.88港元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/13144646352193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0348735423.USD","LU0456827905.SGD","LU0516422440.USD","LU0051755006.USD","SG9999002562.SGD","LU0181495838.USD","LU0043850808.USD","02269","BK1521","LU0307460666.USD","LU0819121731.USD","LU0516422366.SGD","LU0979878070.USD","LU0417516738.SGD","LU1720050803.USD","LU2039709279.SGD","LU0856984785.SGD","LU0823426308.USD","LU1794554557.SGD","LU0456846285.SGD","LU0516422952.EUR","LU0348825331.USD","LU0823426480.USD","LU0359202008.SGD","LU0039217434.USD","BK1576","BK1610","LU1242518857.USD","LU1880383366.USD","LU0359201612.USD","BK1141","LU0572944931.SGD","LU0327786744.USD","LU0516423174.USD","SG9999002463.SGD","LU0516423091.SGD","LU1242518931.SGD","LU1688375341.USD","LU0588546209.SGD","LU0052750758.USD","LU0417516902.SGD","BK1589","LU0320764599.SGD","LU0326950275.SGD","IE00B0JY6N72.USD","LU0708995583.HKD","LU0140636845.USD"],"gpt_icon":0},{"id":"2491833575","title":"药明生物成功入选UNGC\"‘二十年二十佳'企业可持续发展案例\"报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2491833575","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491833575?lang=zh_cn&edition=full","pubTime":"2024-12-12 16:30","pubTimestamp":1733992200,"startTime":"0","endTime":"0","summary":"引领绿色生物药发展，技术创新赋能健康未来 为全行业提供端到端绿色生物药解决方案  上海2024年12月12日 /美通社/ -- 全球领先的合同研究、开发和生产（CRDMO）服务公司药明生物（WuXi Biologics, 2269.HK）宣布，公司的绿色生物药解决方案（Green CRDMO），成功入选联合国全球契约组织（UNGC）\"‘二十年二十佳'企业可持续发展案例\"报告并受邀参加全球路演。药明","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4578414_ZH78414_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU0516422440.USD","LU1880383366.USD","LU0307460666.USD","LU0516422366.SGD","LU1267930730.SGD","LU0320764599.SGD","LU2210149790.SGD","LU1242518931.SGD","LU1804176565.USD","LU0289961442.SGD","LU0456827905.SGD","LU0588546209.SGD","SG9999002562.SGD","LU1688375341.USD","LU2210150020.SGD","ESG","LU0326950275.SGD","LU0516422952.EUR","LU0823426308.USD","BK4585","LU0052750758.USD","LU2039709279.SGD","LU0417516738.SGD","WXXWY","LU0051755006.USD","LU0348735423.USD","LU0039217434.USD","LU0572944931.SGD","LU0043850808.USD","LU0672654240.SGD","LU0823426480.USD","LU2095319765.USD","LU0289960550.SGD","LU1794554557.SGD","LU0979878070.USD","LU0708995401.HKD","02269","LU0359201612.USD","LU2265009873.SGD","LU0511384066.AUD","MSCI","LU0516423174.USD","LU0359202008.SGD","LU1242518857.USD","BK4588","BK1610","BK1589","LU0109391861.USD","IE00B0JY6N72.USD","BK1141"],"gpt_icon":1},{"id":"2490567879","title":"药明生物12月12日收跌1.41% 主力资金逆市抢筹","url":"https://stock-news.laohu8.com/highlight/detail?id=2490567879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490567879?lang=zh_cn&edition=full","pubTime":"2024-12-12 16:15","pubTimestamp":1733991359,"startTime":"0","endTime":"0","summary":"12月12日, 药明生物股价跌1.41%，报收18.16元，成交金额7.27亿元，换手率0.97%，振幅4.23%，量比0.45。药明生物今日主力资金净流入6092万元，上一交易日主力净流入493万元，今日环比增加1135.70%。该股近5个交易日上涨10.58%，主力资金累计净流入1.31亿元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入2.94亿元，其中净流入天数为12日。该股主力净额占比0.08%，港股市场排名86/2652。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212161635a1e88543&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212161635a1e88543&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0051755006.USD","LU1242518857.USD","LU0307460666.USD","LU0039217434.USD","LU1794554557.SGD","LU0348825331.USD","SG9999002562.SGD","LU1688375341.USD","BK1576","LU1242518931.SGD","LU0588546209.SGD","BK1610","LU0516423174.USD","LU0327786744.USD","BK1521","02269","LU0516422952.EUR","LU1880383366.USD","LU0043850808.USD","LU0516422440.USD","LU0359201612.USD","LU0516423091.SGD","LU0052750758.USD","LU0572944931.SGD","LU2039709279.SGD","LU0456827905.SGD","LU0359202008.SGD","LU0819121731.USD","BK1141","LU0348735423.USD","LU0326950275.SGD","LU0417516902.SGD","LU0856984785.SGD","SG9999002463.SGD","LU0320764599.SGD","LU0823426308.USD","LU0708995583.HKD","BK1589","LU0456846285.SGD","LU1720050803.USD","LU0181495838.USD","IE00B0JY6N72.USD","LU0823426480.USD","LU0516422366.SGD","LU0979878070.USD","LU0140636845.USD","LU0417516738.SGD"],"gpt_icon":1},{"id":"2490879827","title":"【券商聚焦】浦银国际对2025年医药板块整体呈乐观态度 看好创新药、医疗器械及CXO","url":"https://stock-news.laohu8.com/highlight/detail?id=2490879827","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490879827?lang=zh_cn&edition=full","pubTime":"2024-12-12 15:52","pubTimestamp":1733989962,"startTime":"0","endTime":"0","summary":"2)医疗器械：看好创新高值耗材、医疗设备板块。康诺亚核心产品CM310将于2025年迎来首个完整年度商业化，作为首个国产重磅IL4R，该行认为其市场潜力巨大。此外，康诺亚研发实力强劲，NewCo形式有助于加快其出海步伐，2025年潜在出海交易有望进一步提振股票行情。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1949533","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823426308.USD","LU2125910500.SGD","LU0417516738.SGD","BK1521","09926","LU0572944931.SGD","159883","06160","02269","CXO","LU1720050803.USD","LU0348784397.USD","IE00B5MMRT66.SGD","LU0979878070.USD","BK1610","IE00B543WZ88.USD","LU2328871848.SGD","03759","00013","SG9999014674.SGD","LU0307460666.USD","LU0196878994.USD","LU0819121731.USD","09996","LU0856984785.SGD","LU0516422366.SGD","01789","BK1191","02268","LU2488822045.USD","BK1589","LU0043850808.USD","159938","06990","09939","LU0348735423.USD","SG9999002562.SGD","LU0327786744.USD","02162","LU0181495838.USD","06978","02190","09997","BK1141","LU0359202008.SGD","BK1100","SG9999002463.SGD","LU2045819591.USD","02359","159992"],"gpt_icon":1},{"id":"2490879846","title":"【券商聚焦】招银国际升药明生物(02269)目标价68.5% 全球生物医药融资复苏 看好其估值与业绩修复","url":"https://stock-news.laohu8.com/highlight/detail?id=2490879846","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490879846?lang=zh_cn&edition=full","pubTime":"2024-12-12 15:51","pubTimestamp":1733989908,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际研报指，预期生物安全法案大概率立法失败，利好药明生物(02269)在较为稳定的经营环境下持续实现业绩增长。随着全球生物医药融资复苏，该行看好公司估值与业绩修复。该行维持药明生物买入评级，上调基于DCF估值的目标价至22.88港元（前值：13.58港元）。该行预计药明生物2024E/25E/26E收入同比增长7.1%/12.4%/13.9%，经调整归母净利润同比增长0.8%/11.1%/13.4%，对应现阶段股价的经调整PE分别为14.9x/13.4x/11.8x。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1949532","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161726","399441","02269"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxibiologics.com","stockEarnings":[{"period":"1week","weight":-0.0438},{"period":"1month","weight":0.1081},{"period":"3month","weight":0.272},{"period":"6month","weight":0.4672},{"period":"1year","weight":-0.4018},{"period":"ytd","weight":-0.425}],"compareEarnings":[{"period":"1week","weight":-0.0125},{"period":"1month","weight":0.0008},{"period":"3month","weight":0.0801},{"period":"6month","weight":0.0939},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.1568}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"药明生物技术有限公司是一家主要从事向生物制剂行业的客户提供就生物发现、开发及生产的端到端解决方案及服务的投资控股公司。该公司主要通过两个分部运营其业务。生物药分部主要从事提供生物药的发现、开发和生产。药明合联（XDC）分部主要从事为抗体偶联药物（ADCs）及各种生物偶联药物提供合同研究、开发及生产组织（CRDMO）服务。该公司主要在国内和国外市场开展其业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.035713},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.034807},{"month":3,"riseRate":0.571429,"avgChangeRate":-0.00624},{"month":4,"riseRate":0.428571,"avgChangeRate":0.021731},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.011574},{"month":6,"riseRate":0.571429,"avgChangeRate":0.069801},{"month":7,"riseRate":0.625,"avgChangeRate":0.059733},{"month":8,"riseRate":0.5,"avgChangeRate":0.030152},{"month":9,"riseRate":0.625,"avgChangeRate":0.034087},{"month":10,"riseRate":0.5,"avgChangeRate":-0.023256},{"month":11,"riseRate":0.5,"avgChangeRate":0.046185},{"month":12,"riseRate":0.5,"avgChangeRate":0.004683}],"exchange":"SEHK","name":"药明生物","nameEN":"WUXI BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明生物(02269)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明生物(02269)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明生物,02269,药明生物股票,药明生物股票老虎,药明生物股票老虎国际,药明生物行情,药明生物股票行情,药明生物股价,药明生物股市,药明生物股票价格,药明生物股票交易,药明生物股票购买,药明生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明生物(02269)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明生物(02269)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}